(Press-News.org) Influenza vaccination rates vary widely in Canada by ethnicity, with black and white Canadians being the least likely to be vaccinated, found a new study in CMAJ (Canadian Medical Association Journal).
Research on vaccination rates among ethnic minorities in Canada is scarce, despite many studies in the United States showing clear disparities in vaccination rates among minorities and whites. However, the findings are not the same in Canada given existing differences in vaccine delivery and populations.
Canadian researchers undertook a study to estimate influenza vaccine coverage across 12 ethnic groups in Canada. They looked at nationally representative data from the 2003, 2005, 2007, 2008 and 2009 cycles of the Canadian Community Health Survey including 437 488 people aged 12 years and older. People representing 12 ethnic groups made up 18% of the sample.
The authors found that Canadians of Filipino (41%), Japanese (38%) and Chinese (35%) backgrounds had much higher vaccination rates than white Canadians (32%) and black Canadians (27%). In people with chronic disease, rates ranged from 34% to 50%.
"Our results show that all ethnic groups, with the exception of black Canadians, had significantly higher uptake of influenza vaccination than white Canadians," writes lead author Susan Quach and principal investigator Dr. Jeffrey Kwong and coauthors. "Variations in coverage levels persisted even after adjusting for other determinants of vaccine uptake, which suggests that there may be unique barriers and misconceptions influencing these groups differently."
The researchers suggest that the varying rates of vaccination between ethnic groups in Canada could be related to many reasons such as exposure to and support of antivaccination messages in the media.
"Our findings should not understate the importance of tackling issues of sociodemographics and access to health care that influence uptake and extend across all ethnic groups in Canada," conclude the authors. "To ensure optimal vaccine coverage, it will be important for public health to work with health care providers, clients and community-based organizations to understand the unique challenges and barriers that affect their communities, and to design appropriate interventions for different populations."
The research was conducted at the Statistics Canada Research Data Centre and Public Health Ontario, with funding from the Canadian Institutes for Health Research (CIHR) and the Public Health Agency of Canada (PHAC) through the PHAC/CIHR Influenza Research Network.
In a related commentary, Dr. Bradford Gessner, Agence de Médecine Préventive, Paris, France suggests that local context may explain the varying rates of vaccination. "This may include access to vaccination programs, attitudes of local clinicians, access to the Internet, the importance of the antivaccine movement, media reporting and bias, actual or perceived prevalence of disease in a population, and assessment of individual risk."
"Rather than focus on race and ethnicity, I suggest a different approach," writes Dr. Gessner. "First, we should acknowledge that vaccination coverage for influenza is low in almost all groups, the optimal target groups are not yet well-defined, and target groups and risk factors for low coverage will vary with place and time. For these reasons, national and local public health agencies should develop interventions that address risk factors at the appropriate level and for all people."
INFORMATION: END
Most pharmaceutical drugs in Canada are manufactured overseas in countries such as India, China and others, yet how can we be confident the drug supply is safe, writes a drug policy researcher in an opinion piece in CMAJ (Canadian Medical Association Journal).
Alarmed by alerts about potentially harmful products such as nonprescription erectile dysfunction drugs with names like Uprizing 2.0 and Ying Da Wang — most from overseas — Alan Cassels began to think about pharmaceutical drugs sold in Canada. Are they safe? Who regulates them?
"Most Canadians probably don't know ...
PHILADELPHIA — How does one's experience of an event get translated into a memory that can be accessed months, even years later? A team led by University of Pennsylvania scientists has come closer to answering that question, identifying key molecules that help convert short-term memories into long-term ones. These proteins may offer a target for drugs that can enhance memory, alleviating some of the cognitive symptoms that characterize conditions including schizophrenia, depression and Parkinson's and Alzheimer's diseases.
Joshua Hawk, now a postdoctoral research fellow ...
Tracking malaria parasites in the liver
Plasmodium falciparum is the most deadly human malaria parasite, causing more than 800,000 deaths per year. After the parasite enters the blood stream, it travels to the liver where it serially invades liver cells (hepatocytes), until it settles down to form a parasitophorous vacuole (PV). Once ensconced in its PV, the parasite undergoes a process known as liver stage (LS) development during which it spawns tens of thousands of new parasites. In this issue of the Journal of Clinical Investigation, Stefan Kappe and colleagues at ...
Iron overload increases the risk for insulin resistance and type 2 diabetes; however, the exact mechanisms that link the two are unknown. In this issue of the Journal of Clinical Investigation, Donald McClain and colleagues at the University of Utah report that serum ferritin levels could predict the presence or absence of metabolic syndrome in humans and were inversely associated with the expression of adiponectin, a blood glucose-regulating protein produced by fat cells (adipocytes). Treatment of adipocytes with iron decreased adiponectin levels, indicating that adipocytes ...
Bethesda, MD—September 10, 2012 – Listed below are the selected highlights for the September 2012 issue of the Genetics Society of America's journal, GENETICS. The September issue is available online at www.genetics.org/content/current. Please credit GENETICS, Vol. 192, September 2012, Copyright © 2012.
ISSUE HIGHLIGHTS
Weak selection and protein evolution, pp. 15-31
Hiroshi Akashi, Naoki Osada, and Tomoko Ohta
The rapid proliferation of genome sequence data has renewed interest in the causes of molecular evolution. The authors review the basis of the "nearly ...
Philadelphia, Pa. (September 10, 2012) – Women and girls are at increased risk of adverse outcomes after surgical treatment for moyamoya disease, an uncommon but serious disease of the brain blood vessels, reports a study in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Although the postoperative risks are increased, patients of both sexes with moyamoya disease achieve significant improvement after surgery. The study was performed ...
September 10, 2012 (SILVER SPRING, Md.) – Scientists used genetic sequencing to discover new evidence that the first vaccine shown to prevent HIV infection in people also affected the viruses in those who did become infected. Viruses with two genetic "footprints" were associated with greater vaccine efficacy. The results were published today in the online edition of the journal Nature.
"This is the first time that we have seen pressure on the virus at the genetic level due to an effective HIV vaccine," said Morgane Rolland, Ph.D., a scientist at the U.S. Military HIV ...
SALT LAKE CITY – Researchers from the University of Utah have gained new insight into the regulation of adult nerve cell generation in the hypothalamus, the part of the brain that regulates many aspects of behavior, mood, and metabolism. In the Sept. 10, 2012, issue of Developmental Cell they report that a cell-to-cell communication network known as the Wnt signaling pathway plays an important role in both the production and specialization of nerve cell precursors in the hypothalamus.
The hypothalamus is a highly complex region of the brain that controls hunger, thirst, ...
BOSTON––A molecule that targets the cell's machinery for breaking down unneeded proteins can kill multiple myeloma cancer cells resistant to the frontline drug Velcade, researchers at Dana-Farber Cancer Institute have found.
In a study published online by the journal Cancer Cell, the investigators report that the small molecule P5091 triggered apoptosis -- programmed cell death -- in drug-resistant myeloma cells grown in the laboratory and in animals. The anti-myeloma effect was even more powerful when researchers combined P5091 with other therapies.
"Velcade was one ...
MADISON – The protein GATA2 is known as a "master regulator" of blood cell development. When a mutation occurs in the gene that makes GATA2, serious blood diseases such as acute myeloid leukemia can result.
Zooming in on the GATA2 gene, UW-Madison researchers and their collaborators at the National Institutes of Health (NIH) have discovered unexpectedly that a small DNA sequence drives this powerful master regulator.
The sequence plays an essential role in controlling GATA2 production and generating self-renewing blood stem cells responsible for the earliest steps ...
